Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 20 de 34
Filter
1.
Trends Parasitol ; 35(8): 588-590, 2019 08.
Article in English | MEDLINE | ID: mdl-31266710

ABSTRACT

A recent paper (Zhang et al., PLoS Biol., 2019) shines remarkable new light onto the malaria antigenic variation story. Using CRISPR/Cas9-targeted chromosome breaks and long-read whole-genome sequencing, they followed the fate of detached subtelomeric PfEMP1/var genes and demonstrated that these initiate cascades of recombination at sites far from the original break.


Subject(s)
Malaria, Falciparum , Malaria , Parasites , Protozoan Proteins/genetics , Animals , Antigenic Variation , Humans , Plasmodium falciparum
2.
Nat Commun ; 10(1): 2060, 2019 05 14.
Article in English | MEDLINE | ID: mdl-31089131

ABSTRACT

Uncontrollable bleeding is a major problem in surgical procedures and after major trauma. Existing hemostatic agents poorly control hemorrhaging from traumatic arterial and cardiac wounds because of their weak adhesion to wet and mobile tissues. Here we design a photo-reactive adhesive that mimics the extracellular matrix (ECM) composition. This biomacromolecule-based matrix hydrogel can undergo rapid gelling and fixation to adhere and seal bleeding arteries and cardiac walls after UV light irradiation. These repairs can withstand up to 290 mm Hg blood pressure, significantly higher than blood pressures in most clinical settings (systolic BP 60-160 mm Hg). Most importantly, the hydrogel can stop high-pressure bleeding from pig carotid arteries with 4~ 5 mm-long incision wounds and from pig hearts with 6 mm diameter cardiac penetration holes. Treated pigs survived after hemostatic treatments with this hydrogel, which is well-tolerated and appears to offer significant clinical advantage as a traumatic wound sealant.


Subject(s)
Adhesives/therapeutic use , Biopolymers/therapeutic use , Hemorrhage/therapy , Hemostatics/therapeutic use , Hydrogels/therapeutic use , Adhesives/chemistry , Adhesives/radiation effects , Animals , Arteries/injuries , Arteries/surgery , Biopolymers/chemistry , Biopolymers/radiation effects , Cell Line , Coronary Vessels/injuries , Coronary Vessels/surgery , Disease Models, Animal , Extracellular Matrix/chemistry , Hemorrhage/etiology , Hemostatics/chemistry , Hemostatics/radiation effects , Humans , Hydrogels/chemistry , Hydrogels/radiation effects , Male , Polymerization/radiation effects , Surgical Wound/complications , Treatment Outcome , Ultraviolet Rays
4.
PLoS One ; 9(1): e83704, 2014.
Article in English | MEDLINE | ID: mdl-24421900

ABSTRACT

The Block 2 region of the merozoite surface protein-1 (MSP-1) of Plasmodium falciparum has been identified as a target of protective immunity by a combination of seroepidemiology and parasite population genetics. Immunogenicity studies in small animals and Aotus monkeys were used to determine the efficacy of recombinant antigens derived from this region of MSP-1 as a potential vaccine antigen. Aotus lemurinus griseimembra monkeys were immunized three times with a recombinant antigen derived from the Block 2 region of MSP-1 of the monkey-adapted challenge strain, FVO of Plasmodium falciparum, using an adjuvant suitable for use in humans. Immunofluorescent antibody assays (IFA) against erythrocytes infected with P. falciparum using sera from the immunized monkeys showed that the MSP-1 Block 2 antigen induced significant antibody responses to whole malaria parasites. MSP-1 Block 2 antigen-specific enzyme-linked immunosorbent assays (ELISA) showed no significant differences in antibody titers between immunized animals. Immunized animals were challenged with the virulent P. falciparum FVO isolate and monitored for 21 days. Two out of four immunized animals were able to control their parasitaemia during the follow-up period, whereas two out of two controls developed fulminating parasitemia. Parasite-specific serum antibody titers measured by IFA were four-fold higher in protected animals than in unprotected animals. In addition, peptide-based epitope mapping of serum antibodies from immunized Aotus showed distinct differences in epitope specificities between protected and unprotected animals.


Subject(s)
Antibody Formation/immunology , Haplorhini/immunology , Malaria Vaccines/immunology , Malaria, Falciparum/immunology , Malaria, Falciparum/prevention & control , Merozoite Surface Protein 1/immunology , Plasmodium falciparum/immunology , Adjuvants, Immunologic , Amino Acid Sequence , Animals , Antibody Specificity/immunology , Antigens, Protozoan/immunology , Epitope Mapping , Epitopes/chemistry , Epitopes/immunology , Haplorhini/blood , Haplorhini/parasitology , Humans , Immunization , Malaria, Falciparum/blood , Malaria, Falciparum/parasitology , Molecular Sequence Data , Parasitemia/immunology , Parasitemia/parasitology , Recombinant Proteins/immunology
5.
Nucleic Acids Res ; 42(4): 2270-81, 2014 Feb.
Article in English | MEDLINE | ID: mdl-24253306

ABSTRACT

Many bacterial, viral and parasitic pathogens undergo antigenic variation to counter host immune defense mechanisms. In Plasmodium falciparum, the most lethal of human malaria parasites, switching of var gene expression results in alternating expression of the adhesion proteins of the Plasmodium falciparum-erythrocyte membrane protein 1 class on the infected erythrocyte surface. Recombination clearly generates var diversity, but the nature and control of the genetic exchanges involved remain unclear. By experimental and bioinformatic identification of recombination events and genome-wide recombination hotspots in var genes, we show that during the parasite's sexual stages, ectopic recombination between isogenous var paralogs occurs near low folding free energy DNA 50-mers and that these sequences are heavily concentrated at the boundaries of regions encoding individual Plasmodium falciparum-erythrocyte membrane protein 1 structural domains. The recombinogenic potential of these 50-mers is not parasite-specific because these sequences also induce recombination when transferred to the yeast Saccharomyces cerevisiae. Genetic cross data suggest that DNA secondary structures (DSS) act as inducers of recombination during DNA replication in P. falciparum sexual stages, and that these DSS-regulated genetic exchanges generate functional and diverse P. falciparum adhesion antigens. DSS-induced recombination may represent a common mechanism for optimizing the evolvability of virulence gene families in pathogens.


Subject(s)
Antigenic Variation/genetics , Antigens, Protozoan/genetics , DNA, Protozoan/chemistry , Plasmodium falciparum/genetics , Protozoan Proteins/genetics , Recombination, Genetic , Antigens, Protozoan/chemistry , Genes, Protozoan , Multigene Family , Nucleic Acid Conformation , Protein Structure, Tertiary , Protozoan Proteins/chemistry , Saccharomyces cerevisiae/genetics
6.
Malar J ; 11: 429, 2012 Dec 21.
Article in English | MEDLINE | ID: mdl-23259643

ABSTRACT

BACKGROUND: The ability of Plasmodium falciparum to undergo antigenic variation, by switching expression among protein variants encoded by multigene families, such as var, rif and stevor, is key to the survival of this parasite in the human host. The RIFIN protein family can be divided into A and B types based on the presence or absence of a 25 amino acid motif in the semi-conserved domain. A particular type B RIFIN, PF13_0006, has previously been shown to be strongly transcribed in the asexual and sexual stages of P. falciparum in vitro. METHODS: Antibodies to recombinant PF13_0006 RIFIN were used in immunofluorescence and confocal imaging of 3D7 parasites throughout the asexual reproduction and sexual development to examine the expression of PF13_0006. Furthermore, reactivity to recombinant PF13_0006 was measured in plasma samples collected from individuals from both East and West African endemic areas. RESULTS: The PF13_0006 RIFIN variant appeared expressed by both released merozoites and gametes after emergence. 7.4% and 12.1% of individuals from East and West African endemic areas, respectively, carry plasma antibodies that recognize recombinant PF13_0006, where the antibody responses were more common among older children. CONCLUSIONS: The stage specificity of PF13_0006 suggests that the diversity of RIFIN variants has evolved to provide multiple specialized functions in different stages of the parasite life cycle. These data also suggest that RIFIN variants antigenically similar to PF13_0006 occur in African parasite populations.


Subject(s)
Membrane Proteins/genetics , Membrane Proteins/immunology , Plasmodium falciparum/genetics , Plasmodium falciparum/immunology , Protozoan Proteins/genetics , Protozoan Proteins/immunology , Adolescent , Adult , Africa/epidemiology , Animals , Antibodies, Protozoan/blood , Antigenic Variation/genetics , Antigens, Protozoan/genetics , Base Sequence , Child , Child, Preschool , DNA, Protozoan/genetics , Endemic Diseases , Female , Gene Expression Regulation, Developmental , Genes, Protozoan , Host-Parasite Interactions/immunology , Humans , Infant , Malaria, Falciparum/epidemiology , Malaria, Falciparum/immunology , Malaria, Falciparum/parasitology , Male , Merozoite Surface Protein 1/metabolism , Merozoites/immunology , Middle Aged , Plasmodium falciparum/growth & development , Young Adult
7.
J Vis Exp ; (68)2012 Oct 07.
Article in English | MEDLINE | ID: mdl-23070076

ABSTRACT

Adhesion of Plasmodium falciparum infected erythrocytes (IE) to human endothelial receptors during malaria infections is mediated by expression of PfEMP1 protein variants encoded by the var genes. The haploid P. falciparum genome harbors approximately 60 different var genes of which only one has been believed to be transcribed per cell at a time during the blood stage of the infection. How such mutually exclusive regulation of var gene transcription is achieved is unclear, as is the identification of individual var genes or sub-groups of var genes associated with different receptors and the consequence of differential binding on the clinical outcome of P. falciparum infections. Recently, the mutually exclusive transcription paradigm has been called into doubt by transcription assays based on individual P. falciparum transcript identification in single infected erythrocytic cells using RNA fluorescent in situ hybridization (FISH) analysis of var gene transcription by the parasite in individual nuclei of P. falciparum IE(1). Here, we present a detailed protocol for carrying out the RNA-FISH methodology for analysis of var gene transcription in single-nuclei of P. falciparum infected human erythrocytes. The method is based on the use of digoxigenin- and biotin- labeled antisense RNA probes using the TSA Plus Fluorescence Palette System(2) (Perkin Elmer), microscopic analyses and freshly selected P. falciparum IE. The in situ hybridization method can be used to monitor transcription and regulation of a variety of genes expressed during the different stages of the P. falciparum life cycle and is adaptable to other malaria parasite species and other organisms and cell types.


Subject(s)
DNA, Protozoan/genetics , In Situ Hybridization, Fluorescence/methods , Plasmodium falciparum/genetics , Single-Cell Analysis/methods , DNA, Protozoan/chemistry , Erythrocytes/parasitology , Humans , Plasmodium falciparum/chemistry , RNA, Antisense/genetics , Transcription, Genetic
8.
Infect Immun ; 80(3): 1280-7, 2012 Mar.
Article in English | MEDLINE | ID: mdl-22202121

ABSTRACT

Merozoite surface protein 1 (MSP1) is a target for malaria vaccine development. Antibodies to the 19-kDa carboxy-terminal region referred to as MSP1(19) inhibit erythrocyte invasion and parasite growth, with some MSP1-specific antibodies shown to inhibit the proteolytic processing of MSP1 that occurs at invasion. We investigated a series of antibodies purified from rabbits immunized with MSP1(19) and AMA1 recombinant proteins for their ability to inhibit parasite growth, initially looking at MSP1 processing. Although significant inhibition of processing was mediated by several of the antibody samples, there was no clear relationship with overall growth inhibition by the same antibodies. However, no antibody samples inhibited processing but not invasion, suggesting that inhibition of MSP1 processing contributes to but is not the only mechanism of antibody-mediated inhibition of invasion and growth. Examining other mechanisms by which MSP1-specific antibodies inhibit parasite growth, we show that MSP1(19)-specific antibodies are taken up into invaded erythrocytes, where they persist for significant periods and result in delayed intracellular parasite development. This delay may result from antibody interference with coalescence of MSP1(19)-containing vesicles with the food vacuole. Antibodies raised against a modified recombinant MSP1(19) sequence were more efficient at delaying intracellular growth than those to the wild-type protein. We propose that antibodies specific for MSP1(19) can mediate inhibition of parasite growth by at least three mechanisms: inhibition of MSP1 processing, direct inhibition of invasion, and inhibition of parasite development following invasion. The balance between mechanisms may be modulated by modifying the immunogen used to induce the antibodies.


Subject(s)
Antibodies, Protozoan/immunology , Merozoite Surface Protein 1/immunology , Merozoite Surface Protein 1/metabolism , Merozoites/growth & development , Merozoites/immunology , Plasmodium falciparum/growth & development , Plasmodium falciparum/immunology , Animals , Erythrocytes/parasitology , Rabbits
9.
Malar J ; 10: 255, 2011 Sep 01.
Article in English | MEDLINE | ID: mdl-21880156

ABSTRACT

Since 2000, under the Fifth and subsequent Framework Programmes, the European Commission has funded research to spur the development of a malaria vaccine. This funding has contributed to the promotion of an integrated infrastructure consisting of European basic, applied and clinical scientists in academia and small and medium enterprises, together with partners in Africa. Research has added basic understanding of what is required of a malaria vaccine, allowing selected candidates to be prioritized and some to be moved forward into clinical trials. To end the health burden of malaria, and its economic and social impact on development, the international community has now essentially committed itself to the eventual eradication of malaria. Given the current tentative advances towards elimination or eradication of malaria in many endemic areas, malaria vaccines constitute an additional and almost certainly essential component of any strategic plan to interrupt transmission of malaria. However, funding for malaria vaccines has been substantially reduced in the Seventh Framework Programme compared with earlier Framework Programmes, and without further support the gains made by earlier European investment will be lost.


Subject(s)
Biomedical Research/economics , Capital Financing/trends , Drug Discovery/economics , Malaria Vaccines/immunology , Malaria/prevention & control , Europe , Humans , Malaria/epidemiology
10.
J Infect Dis ; 203(11): 1679-85, 2011 Jun 01.
Article in English | MEDLINE | ID: mdl-21592998

ABSTRACT

Placental malaria infections are caused by Plasmodium falciparum-infected red blood cells sequestering in the placenta by binding to chondroitin sulfate A, mediated by VAR2CSA, a variant of the PfEMP1 family of adhesion antigens. Recent studies have shown that many P. falciparum genomes have multiple genes coding for different VAR2CSA proteins, and parasites with >1 var2csa gene appear to be more common in pregnant women with placental malaria than in nonpregnant individuals. We present evidence that, in pregnant women, parasites containing multiple var2csa-type genes possess a selective advantage over parasites with a single var2csa gene. Accumulation of parasites with multiple copies of the var2csa gene during the course of pregnancy was also correlated with the development of antibodies involved in blocking VAR2CSA adhesion. The data suggest that multiplicity of var2csa-type genes enables P. falciparum parasites to persist for a longer period of time during placental infections, probably because of their greater capacity for antigenic variation and evasion of variant-specific immune responses.


Subject(s)
Antigens, Protozoan/genetics , Malaria, Falciparum/parasitology , Plasmodium falciparum/genetics , Pregnancy Complications, Infectious/parasitology , Protozoan Proteins/genetics , Adolescent , Adult , Anemia/blood , Anemia/genetics , Anemia/parasitology , Antibodies, Protozoan/blood , Birth Weight , Female , Gene Dosage/genetics , Genetic Variation , Humans , Immunoglobulin G/blood , Longitudinal Studies , Malaria, Falciparum/blood , Polymerase Chain Reaction , Pregnancy , Pregnancy Complications, Infectious/blood , Selection, Genetic
11.
Adv Appl Microbiol ; 74: 77-96, 2011.
Article in English | MEDLINE | ID: mdl-21459194

ABSTRACT

How immunity to malaria develops remains one of the great unresolved issues in bio-medicine and resolution of its various paradoxes is likely to be the key to developing effective malaria vaccines. The basic epidemiological observations are; under conditions of intense natural transmission, humans do become immune to P. falciparum malaria, but this is a slow process requiring multiple disease episodes which many, particularly young children, do not survive. Adult survivors are immune to the symptoms of malaria, and unless pregnant, can control the growth of most or all new inoculations. Sterile immunity is not achieved and chronic parasitization of apparently healthy adults is the norm. In this article, we analyse the best understood malaria "antigenic variation" system, that based on Plasmodium falciparum's PfEMP1-type cytoadhesion antigens, and critically review recent literature on the function and control of this multi-gene family of parasite variable surface antigens.


Subject(s)
Antigenic Variation , Plasmodium falciparum , Animals , Antigens, Protozoan , Antigens, Surface , Erythrocytes , Humans , Malaria, Falciparum , Protozoan Proteins
12.
J Biol Chem ; 286(18): 15908-17, 2011 May 06.
Article in English | MEDLINE | ID: mdl-21398524

ABSTRACT

Malaria during pregnancy is a major health problem for African women. The disease is caused by Plasmodium falciparum malaria parasites, which accumulate in the placenta by adhering to chondroitin sulfate A (CSA). The interaction between infected erythrocytes and the placental receptor is mediated by a parasite expressed protein named VAR2CSA. A vaccine protecting pregnant women against placental malaria should induce antibodies inhibiting the interaction between VAR2CSA and CSA. Much effort has been put into defining the part of the 350 kDa VAR2CSA protein that is responsible for binding. It has been shown that full-length recombinant VAR2CSA binds specifically to CSA with high affinity, however to date no sub-fragment of VAR2CSA has been shown to interact with CSA with similar affinity or specificity. In this study, we used a biosensor technology to examine the binding properties of a panel of truncated VAR2CSA proteins. The experiments indicate that the core of the CSA-binding site is situated in three domains, DBL2X-CIDR(PAM) and a flanking domain, located in the N-terminal part of VAR2CSA. Furthermore, recombinant VAR2CSA subfragments containing this region elicit antibodies with high parasite adhesion blocking activity in animal immunization experiments.


Subject(s)
Chondroitin Sulfates/chemistry , Peptide Mapping , Plasmodium falciparum/chemistry , Animals , Antigens, Protozoan , Biosensing Techniques/methods , Chondroitin Sulfates/genetics , Chondroitin Sulfates/immunology , Chondroitin Sulfates/metabolism , Erythrocytes/immunology , Erythrocytes/metabolism , Erythrocytes/parasitology , Female , Humans , Malaria Vaccines/chemistry , Malaria Vaccines/genetics , Malaria Vaccines/immunology , Malaria Vaccines/metabolism , Malaria, Falciparum/epidemiology , Malaria, Falciparum/genetics , Malaria, Falciparum/immunology , Malaria, Falciparum/metabolism , Malaria, Falciparum/prevention & control , Placenta/immunology , Placenta/metabolism , Placenta/parasitology , Plasmodium falciparum/genetics , Plasmodium falciparum/immunology , Plasmodium falciparum/metabolism , Pregnancy , Pregnancy Complications, Parasitic/epidemiology , Pregnancy Complications, Parasitic/genetics , Pregnancy Complications, Parasitic/immunology , Pregnancy Complications, Parasitic/metabolism , Pregnancy Complications, Parasitic/prevention & control , Protein Binding , Protein Structure, Tertiary , Rats , Rats, Wistar , Recombinant Proteins/chemistry , Recombinant Proteins/genetics , Recombinant Proteins/immunology , Recombinant Proteins/metabolism
13.
Int J Parasitol ; 41(1): 71-80, 2011 Jan.
Article in English | MEDLINE | ID: mdl-20816844

ABSTRACT

The cell division cycle and mitosis of intra-erythrocytic (IE) Plasmodium falciparum are poorly understood aspects of parasite development which affect malaria molecular pathogenesis. Specifically, the timing of the multiple gap (G), DNA synthesis (S) and chromosome separation (M) phases of parasite mitosis are not well defined, nor whether genome divisions are immediately followed by cleavage of the nuclear envelope. Curiously, daughter merozoite numbers do not follow the geometric expansion expected from equal numbers of binary divisions, an outcome difficult to explain using the standard model of cell cycle regulation. Using controlled synchronisation techniques, confocal microscopy to visualise key organelles and fluorescence in situ hybridization (FISH) to follow the movements and replication of genes and telomeres, we have re-analysed the timing and progression of mitotic events. The asynchronous duplications of the P. falciparum centrosome equivalents, the centriolar plaques, are established and these are correlated with chromosome and nuclear divisions in a new model of P. falciparum schizogony. Our results improve the resolution of the cell cycle and its phases during P. falciparum IE development, showing that asynchronous, independent nuclear division occurs during schizogony, with the centriolar plaques playing a major role in regulating mitotic progression.


Subject(s)
Cell Division , Erythrocytes/parasitology , Plasmodium falciparum/physiology , Humans , In Situ Hybridization, Fluorescence , Microscopy, Confocal , Organelles/physiology
14.
Malar J ; 9: 325, 2010 Nov 15.
Article in English | MEDLINE | ID: mdl-21078147

ABSTRACT

BACKGROUND: The PFD1235w Plasmodium falciparum erythrocyte membrane protein 1 (PfEMP1) antigen is associated with severe malaria in children and can be expressed on the surface of infected erythrocytes (IE) adhering to ICAM1. However, the exact three-dimensional structure of this PfEMP1 and its surface-exposed epitopes are unknown. An insect cell and Escherichia coli based system was used to express single and double domains encoded by the pfd1235w var gene. The resulting recombinant proteins have been evaluated for yield and purity and their ability to induce rat antibodies, which react with the native PFD1235w PfEMP1 antigen expressed on 3D7PFD1235w-IE. Their recognition by human anti-malaria antibodies from previously infected Tanzanian donors was also analysed. METHODS: The recombinant proteins were run on SDS-PAGE and Western blots for quantification and size estimation. Insect cell and E. coli-produced recombinant proteins were coupled to a bead-based Luminex assay to measure the plasma antibody reactivity of 180 samples collected from Tanzanian individuals. The recombinant proteins used for immunization of rats and antisera were also tested by flow cytometry for their ability to surface label 3D7PFD1235w-IE. RESULTS: All seven pAcGP67A constructs were successfully expressed as recombinant protein in baculovirus-infected insect cells and subsequently produced to a purity of 60-97% and a yield of 2-15 mg/L. By comparison, only three of seven pET101/D-TOPO constructs expressed in the E. coli system could be produced at all with purity and yield ranging from 3-95% and 6-11 mg/L. All seven insect cell, but only two of the E. coli produced proteins induced antibodies reactive with native PFD1235w expressed on 3D7PFD1235w-IE. The recombinant proteins were recognized in an age- and transmission intensity-dependent manner by antibodies from 180 Tanzanian individuals in a bead-based Luminex assay. CONCLUSIONS: The baculovirus based insect cell system was distinctly superior to the E. coli expression system in producing a larger number of different recombinant PFD1235w protein domains and these were significantly easier to purify at a useful yield. However, proteins produced in both systems were able to induce antibodies in rats, which can recognize the native PFD1235w on the surface of IE.


Subject(s)
Antibodies, Protozoan/blood , Immunoglobulin G/blood , Malaria Vaccines/immunology , Malaria, Falciparum/immunology , Malaria, Falciparum/prevention & control , Protozoan Proteins/immunology , Adolescent , Animals , Baculoviridae/genetics , Cell Line , Child , Child, Preschool , Escherichia coli/genetics , Humans , Insecta , Malaria Vaccines/genetics , Malaria Vaccines/isolation & purification , Protozoan Proteins/genetics , Protozoan Proteins/isolation & purification , Rats , Tanzania , Vaccines, Synthetic/genetics , Vaccines, Synthetic/immunology , Vaccines, Synthetic/isolation & purification , Young Adult
15.
PLoS Pathog ; 6(9): e1001083, 2010 Sep 02.
Article in English | MEDLINE | ID: mdl-20824088

ABSTRACT

The Plasmodium falciparum erythrocyte membrane protein 1 (PfEMP1) antigens play a major role in cytoadhesion of infected erythrocytes (IE), antigenic variation, and immunity to malaria. The current consensus on control of variant surface antigen expression is that only one PfEMP1 encoded by one var gene is expressed per cell at a time. We measured var mRNA transcript levels by real-time Q-PCR, analysed var gene transcripts by single-cell FISH and directly compared these with PfEMP1 antigen surface expression and cytoadhesion in three different antibody-selected P. falciparum 3D7 sub-lines using live confocal microscopy, flow cytometry and in vitro adhesion assays. We found that one selected parasite sub-line simultaneously expressed two different var genes as surface antigens, on single IE. Importantly, and of physiological relevance to adhesion and malaria pathogenesis, this parasite sub-line was found to bind both CD31/PECAM1 and CD54/ICAM1 and to adhere twice as efficiently to human endothelial cells, compared to infected cells having only one PfEMP1 variant on the surface. These new results on PfEMP1 antigen expression indicate that a re-evaluation of the molecular mechanisms involved in P. falciparum adhesion and of the accepted paradigm of absolutely mutually exclusive var gene transcription is required.


Subject(s)
Erythrocytes/metabolism , Erythrocytes/parasitology , Intercellular Adhesion Molecule-1/metabolism , Malaria, Falciparum/metabolism , Plasmodium falciparum/pathogenicity , Platelet Endothelial Cell Adhesion Molecule-1/metabolism , Protozoan Proteins/metabolism , Antigenic Variation , Antigens, Surface/metabolism , Blotting, Northern , Blotting, Western , Cell Adhesion , Cell Movement , Enzyme-Linked Immunosorbent Assay , Flow Cytometry , Humans , Immunoenzyme Techniques , In Situ Hybridization, Fluorescence , Intercellular Adhesion Molecule-1/genetics , Malaria, Falciparum/genetics , Malaria, Falciparum/parasitology , Plasmodium falciparum/genetics , Platelet Endothelial Cell Adhesion Molecule-1/genetics , Protozoan Proteins/genetics , Protozoan Proteins/immunology , RNA, Messenger/genetics , Reverse Transcriptase Polymerase Chain Reaction , Transcription, Genetic
16.
Malar J ; 9: 100, 2010 Apr 19.
Article in English | MEDLINE | ID: mdl-20403153

ABSTRACT

BACKGROUND: Infected humans make protective antibody responses to the PfEMP1 adhesion antigens exported by Plasmodium falciparum parasites to the erythrocyte membrane, but little is known about the kinetics of this antibody-receptor binding reaction or how the topology of PfEMP1 on the parasitized erythrocyte membrane influences antibody association with, and dissociation from, its antigenic target. METHODS: A Quartz Crystal Microbalance biosensor was used to measure the association and dissociation kinetics of VAR2CSA PfEMP1 binding to human monoclonal antibodies. Immuno-fluorescence microscopy was used to visualize antibody-mediated adhesion between the surfaces of live infected erythrocytes and atomic force microscopy was used to obtain higher resolution images of the membrane knobs on the infected erythrocyte to estimate knob surface areas and model VAR2CSA packing density on the knob. RESULTS: Kinetic analysis indicates that antibody dissociation from the VAR2CSA PfEMP1 antigen is extremely slow when there is a high avidity interaction. High avidity binding to PfEMP1 antigens on the surface of P. falciparum-infected erythrocytes in turn requires bivalent cross-linking of epitopes positioned within the distance that can be bridged by antibody. Calculations of the surface area of the knobs and the possible densities of PfEMP1 packing on the knobs indicate that high-avidity cross-linking antibody reactions are constrained by the architecture of the knobs and the large size of PfEMP1 molecules. CONCLUSIONS: High avidity is required to achieve the strongest binding to VAR2CSA PfEMP1, but the structures that display PfEMP1 also tend to inhibit cross-linking between PfEMP1 antigens, by holding many binding epitopes at distances beyond the 15-18 nm sweep radius of an antibody. The large size of PfEMP1 will also constrain intra-knob cross-linking interactions. This analysis indicates that effective vaccines targeting the parasite's vulnerable adhesion receptors should primarily induce strongly adhering, high avidity antibodies whose association rate constant is less important than their dissociation rate constant.


Subject(s)
Antigens, Protozoan/immunology , Plasmodium falciparum/immunology , Protozoan Proteins/immunology , Antibodies, Protozoan/immunology , Antigens, Protozoan/metabolism , Binding Sites , Erythrocyte Membrane/immunology , Erythrocyte Membrane/parasitology , Erythrocyte Membrane/ultrastructure , Humans , Immunoglobulin G/immunology , Kinetics , Microscopy, Atomic Force , Microscopy, Confocal/methods , Microscopy, Fluorescence , Protein Binding , Protozoan Proteins/metabolism
17.
PLoS One ; 4(8): e6667, 2009 Aug 19.
Article in English | MEDLINE | ID: mdl-19690615

ABSTRACT

BACKGROUND: The var2csa gene encodes a Plasmodium falciparum adhesion receptor which binds chondroitin sulfate A (CSA). This var gene is more conserved than other PfEMP1/var genes and is found in all P. falciparum isolates. In isolates 3D7, FCR3/It4 and HB3, var2csa is transcribed from a sub-telomeric position on the left arm of chromosome 12, but it is not known if this location is conserved in all parasites. Genome sequencing indicates that the var2csa gene is duplicated in HB3, but whether this is true in natural populations is uncertain. METHODOLOGY/PRINCIPAL FINDINGS: To assess global variation in the VAR2CSA protein, sequence variation in the DBL2X region of var2csa genes in 54 P.falciparum samples was analyzed. Chromosome mapping of var2csa loci was carried out and a quantitative PCR assay was developed to estimate the number of var2csa genes in P.falciparum isolates from the placenta of pregnant women and from the peripheral circulation of other malaria patients. Sequence analysis, gene mapping and copy number quantitation in P.falciparum isolates indicate that there are at least two loci and that both var2csa-like genes can be transcribed. All VAR2CSA DBL2X domains fall into one of two distinct phylogenetic groups possessing one or the other variant of a large (approximately 26 amino acid) dimorphic motif, but whether either motif variant is linked to a specific locus is not known. CONCLUSIONS/SIGNIFICANCE: Two or more related but distinct var2csa-type PfEMP1/var genes exist in many P. falciparum isolates. One gene is on chromosome 12 but additional var2csa-type genes are on different chromosomes in different isolates. Multiplicity of var2csa genes appears more common in infected placentae than in samples from non-pregnant donors indicating a possible advantage of this genotype in pregnancy associated malaria.


Subject(s)
Chromosome Mapping , Plasmodium falciparum/genetics , Protozoan Proteins/genetics , Animals , Base Sequence , Blotting, Southern , DNA Primers , Electrophoresis, Gel, Pulsed-Field , Models, Molecular , Phylogeny , Polymerase Chain Reaction , Protozoan Proteins/chemistry
18.
Parasitol Int ; 58(4): 478-80, 2009 Dec.
Article in English | MEDLINE | ID: mdl-19616120

ABSTRACT

The var genes encode a family of adhesion receptor proteins, Plasmodium falciparum erythrocyte membrane protein 1 (PfEMP1), which profoundly influence malaria pathogenesis. Only a single var gene is transcribed and one PfEMP1 expressed per P.falciparum parasite. Here we present the in vivo transcript distribution of var genes in a P. falciparum-infected non-immune individual and show that the initial expression of PfEMP1 is based on a strategy that allows all or most variants of PfEMP1s to be expressed by the parasite population at the onset of the blood stage infection.


Subject(s)
Erythrocytes/parasitology , Gene Expression Regulation , Plasmodium falciparum/metabolism , Protozoan Proteins/metabolism , Animals , Antigenic Variation , Gene Expression Profiling , Humans , Plasmodium falciparum/genetics , Protozoan Proteins/genetics , Transcription, Genetic
19.
Malar J ; 7: 101, 2008 Jun 05.
Article in English | MEDLINE | ID: mdl-18533996

ABSTRACT

BACKGROUND: The insertion of parasite antigens into the host erythrocyte membrane and the structure and distribution of Plasmodium falciparum adhesion receptors on that membrane are poorly understood. Laser scanning confocal microscopy (LSCM) and a novel labelling and fixation method have been used to obtain high resolution immuno-fluorescent images of erythrocyte surface PfEMP1 and internal antigens which allow analysis of the accumulation of PfEMP1 on the erythrocyte membrane during asexual development. METHODS: A novel staining technique has been developed which permits distinction between erythrocyte surface PfEMP1 and intracellular PfEMP1, in parasites whose nuclear material is exceptionally well resolved. Primary antibody detection by fluorescence is carried out on the live parasitized erythrocyte. The surface labelled cells are then fixed using paraformaldehyde and permeabilized with a non-ionic detergent to permit access of antibodies to internal parasite antigens. Differentiation between surface and internal antigens is achieved using antibodies labelled with different fluorochromes and confocal microscopy RESULTS: Surface exposed PfEMP1 is first detectable by antibodies at the trophozoite stage of intracellular parasite development although the improved detection method indicates that there are differences between different laboratory isolates in the kinetics of accumulation of surface-exposed PfEMP1. CONCLUSION: A sensitive method for labelling surface and internal PfEMP1 with up to three different fluorochromes has been developed for laser scanning confocal optical microscopy and the analysis of the developmental expression of malaria adhesion antigens.


Subject(s)
Cell Adhesion , Erythrocyte Membrane , Erythrocytes , Plasmodium falciparum/metabolism , Protozoan Proteins/analysis , Staining and Labeling/methods , Amino Acid Sequence , Animals , Erythrocyte Membrane/parasitology , Erythrocyte Membrane/ultrastructure , Erythrocytes/parasitology , Erythrocytes/ultrastructure , Humans , Microscopy, Confocal/methods , Microscopy, Fluorescence , Molecular Sequence Data , Plasmodium falciparum/pathogenicity , Protozoan Proteins/chemistry , Rabbits , Tissue Fixation/methods
20.
Clin Vaccine Immunol ; 15(9): 1345-55, 2008 Sep.
Article in English | MEDLINE | ID: mdl-18550731

ABSTRACT

Immunogenicity testing of Plasmodium falciparum antigens being considered as malaria vaccine candidates was undertaken in rabbits. The antigens compared were recombinant baculovirus MSP-1(19) and five Pichia pastoris candidates, including two versions of MSP-1(19), AMA-1 (domains I and II), AMA-1+MSP-1(19), and fused AMA-1/MSP-1(19)). Animals were immunized with equimolar amounts of each antigen, formulated in Montanide ISA720. The specificities and titers of antibodies were compared using immunofluorescence assays and enzyme-linked immunosorbent assay (ELISA). The antiparasite activity of immunoglobulin G (IgG) in in vitro cultures was determined by growth inhibition assay, flow cytometry, lactate dehydrogenase assay, and microscopy. Baculovirus MSP-1(19) immunizations produced the highest parasite-specific antibody titers in immunofluorescence assays. In ELISAs, baculovirus-produced MSP-1(19) induced more antibodies than any other single MSP-1(19) immunogen and three times more MSP-1(19) specific antibodies than the AMA-1/MSP-1(19) fusion. Antibodies induced by baculovirus MSP-1(19) gave the highest levels of growth inhibition in HB3 and 3D7 parasite cultures, followed by AMA-1+MSP-1(19) and the AMA-1/MSP-1(19) fusion. With the FCR3 isolate (homologous to the AMA-1 construct), antibodies to the three AMA-1-containing candidates gave the highest levels of growth inhibition at high IgG concentrations, but antibodies to baculovirus MSP-1(19) inhibited as well or better at lower IgG concentrations. The two P. pastoris-produced MSP-1(19)-induced IgGs conferred the lowest growth inhibition. Comparative analysis of immunogenicity of vaccine antigens can be used to prioritize candidates before moving to expensive GMP production and clinical testing. The assays used have given discriminating readouts but it is not known whether any of them accurately reflect clinical protection.


Subject(s)
Antigens, Protozoan/immunology , Malaria Vaccines/immunology , Malaria/prevention & control , Plasmodium falciparum/immunology , Adjuvants, Immunologic/administration & dosage , Animals , Antibodies, Protozoan/blood , Antibodies, Protozoan/immunology , Baculoviridae/genetics , Enzyme-Linked Immunosorbent Assay/methods , Fluorescent Antibody Technique, Indirect/methods , Immunoglobulin G/blood , Immunoglobulin G/immunology , Malaria/immunology , Mannitol/administration & dosage , Mannitol/analogs & derivatives , Microbial Viability , Oleic Acids/administration & dosage , Pichia/genetics , Plasmodium falciparum/growth & development , Rabbits , Vaccines, Synthetic/immunology
SELECTION OF CITATIONS
SEARCH DETAIL
...